维普中文期刊产品整合服务
28篇 您的检索式:作者名="RALPH GS"
    题名 作者 年代 出处 被引量
1VEGF delivery with retrogradely transported lentiveetor prolongs survival in a mouse ALS model 显示文摘Azzouz M Ralph GS Storkebaum E 2004Nature2004,429,6990:1
2Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia 显示文摘Jarraya B Boulet B Ralph GS 2009Sci Transl Med2009,1,:1
3VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model显示文摘AZZOUZ M RALPH GS STORKEBAUM E 2004Nature2004,429,6990:1
4Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model 显示文摘Ralph GS Radcliffe PA Day DM 2005Nat Med2005,11,4:1
5VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model显示文摘Azzouz M Ralph GS Storkebaum E 2004Nature2004,429,:1
6Long-term safety and tolerabi- ]ity of ProSavin, a lentiviralvector-based gene therapy for Parkinson's disease: a doseescalation, open-label, phase 1/2 trial 显示文摘Palfi S Gurruchaga JM Ralph GS 2014Lancet2014,283,9923:1
7Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors显示文摘Ralph GS Binley K Wong LF 2006Clin Sci(Lond)2006,110,1:1
8VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model显示文摘Azzouz M Ralph GS Storkebaum E 2004Nature2004,429,6990:1
9Lentiviral-mediated del- ivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus 显示文摘Wong LF Ralph GS Walmsley LE 2005Mol Ther2005,11,1:1
10Silencing mutant SODI using RNAi protects against neurodegeneration and extends survival in an ALS model显示文摘Ralph GS Radcliffe PA Day DM 2005Nat Med2005,11,:1
11Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model 显示文摘Ralph GS Radcliffe PA Day DM 2005Nat Med2005,11,4:1
12VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model显示文摘Azzouz M Ralph GS Storkebaum E 2004Nature2004,429,6990:1
13Targeting of tetracycline-regulatable transgene expression specifically to neural and glial cell populations using adenoviral vectors显示文摘Ralph GS Bienemann A Harding TC 2000Neuroreport2000,11,:1
14Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 112 trial显示文摘Palfi S CurruchagaJM Ralph GS 2014Lancet2014,383,9923:1
15Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALD model 显示文摘Ralph GS Radcliffe PA Day DM 2005Nature Med2005,11,:1
16Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial 显示文摘Palfi S Gurruchaga JM Ralph GS 2014Lancet2014,383,9923:1
17Dopamine gene therapy for Parkinsou' s disease in a nonhuman primate without associated dyskinesia显示文摘Jarraya B Boulet S Ralph GS 2009Sci Transl Med2009,1,:1
18Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson' s disease : a dose escalation, open-label, phase 1/2 trial显示文摘Palfi S Gurruchaga JM Ralph GS 2014Lancet2014,383,:1
19Silencing mutant SOD1 using RNAi protects against neurodegenera- tion and extends survival in an ALS model显示文摘Ralph GS Radeliffe PA Day DM 2005Nat Med2005,11,:1
20VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model显示文摘Azzouz M Ralph GS Storkebaum E 2004Nature2004,429,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费